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Abstract: Vestibular schwannoma (VS) originates from Schwann cells in the superior or inferior
vestibular nerve. Identifying the precise origin will help in determining the optimal surgical approach.
We retrospectively analyzed the preoperative vestibular function test according to VS origin to
determine whether the test is a valuable indicator of tumor origin. Forty-seven patients with VS
(male:female = 18:29, mean age: 54.06 ± 13.50 years) underwent the cochleovestibular function test
(pure-tone audiometry, caloric test, video head impulse test (vHIT), cervical and ocular vestibular-
evoked myogenic potential, and posturography). All patients then underwent surgical removal of
VS, and the schwannoma origin was confirmed. The tumor originated from the superior vestibular
nerve (SVN group) in 21 patients, the inferior vestibular nerve (IVN group) in 26 patients, and an
undetermined site in eight patients. The only value that differed significantly among the groups
was the gain of the vestibular-ocular reflex (VOR) in the ipsilesional posterior canal (iPC) during
the vHIT. Our results indicate that VOR gain in the iPC may be used to predict the nerve origin in
patients with VS. Other cochleovestibular function tests have limited value to discriminate nerve
origins, especially in cases of medium to large VS.
Keywords: vestibular schwannoma; vestibular function test; video head impulse test; superior
vestibular nerve; inferior vestibular nerve
1. Introduction
Vestibular schwannoma (VS), also known as acoustic neuroma, is a benign, slow-
growing tumor at the glial-Schwann cell junction of the vestibular nerve [1,2]. The majority
of VS originates from one of the two vestibular divisions of the eighth cranial nerve: the
superior vestibular nerve (SVN) or the inferior vestibular nerve (IVN); less frequently,
it originates from the cochlear or facial nerves [3]. The goal of VS surgery is to achieve
complete removal of the tumor with minimal postoperative morbidity and mortality [4].
This can be achieved by accurately predicting the origin of VS, as hearing preservation is
often better for VS arising from the SVN [4–8]. Thus, preoperative identification of the VS
origin is of great interest for surgeons. Knowledge of the nerve origin will help determine
the optimal surgical approach [4,9].
Given the dependency of the vestibular nerve function, the SVN transmits the signal
of the anterior canal, horizontal canal, and utricle, and the IVN transmits the signal of
the saccule and posterior canals. Each integrity can be measured indirectly through the
caloric test and ocular vestibular-evoked myogenic potential (oVEMP) for the SVN and
cervical vestibular-evoked myogenic potential (cVEMP) for the IVN [10]. Therefore, several
attempts have been made to preoperatively predict the origin using various vestibular
function tests, including the caloric test, cVEMP, and oVEMP [6,11–13]; however, these
attempts have been unsuccessful or limited, particularly in cases of large tumors. The video
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head impulse test (vHIT), a relatively new vestibular-ocular response (VOR) test method,
can quantitatively measure the VOR gain, as well as identify saccades on the horizontal
canals (HCs), anterior canals (ACs), and posterior canals (PCs) [14]. However, there is
limited information regarding the function of the three semicircular canals using vHIT,
which may determine the origin of VS [15–17].
In most cases, the origin of VS can be determined intraoperatively by an experienced
surgeon. Thus, the primary purpose of this study was to retrospectively analyze preopera-
tive vestibular function tests according to VS origin, which was confirmed intraoperatively,
to determine whether the various vestibular function tests can be used to distinguish
tumor origin.
2. Materials and Methods
2.1. Patients
Medical records of 55 patients who underwent VS surgery in a single tertiary hos-
pital between March 2019 and August 2020 were retrospectively reviewed. Among the
55 patients, the nerve origin of the tumor in eight patients could not clearly be identified
during the surgery; therefore, they were not included in further analysis. Consequently,
47 patients were enrolled in the present study. This study was approved by the institutional
review board of Severance Hospital in Seoul, Korea (project number 4-2021-0089). As this
was a retrospective study, the requirement for informed consent was waived.
2.2. Tumor Evaluation
High-resolution axial T2-weighted FIESTA sequences were used to measure tumor
size, defined as the maximal diameter of the extrameatal portion in the axial magnetic
resonance imaging (MRI) results. Tumor grade was defined by Koos grade [18] and Han-
nover classification [19] based on the MRI findings (Table 1). The tumor subclassification
(cystic or solid type) was completed by a specialized radiologist; a cystic tumor was defined
when the cystic portion exceeded 50% of the tumor volume. The origin of the tumor was
determined in the operation room by a single experienced surgeon (more than 300 cases of
skull-base surgery, I.S. Moon), and histopathology was used to confirm whether the tumor
was a schwannoma. The surgeon was uninformed about the results of vestibular function
tests before and during the surgery.
Table 1. Patient demographics and tumor characteristics.
Characteristics Tumor Origin
All Patients (n = 47) SVN (n = 21) IVN (n = 26) p-Value
Age 54.06 ± 13.50 53.62 ± 13.40 54.42 ± 13.83 0.84
M:F 18:29 8:13 10:16 1
R:L 19:28 10:11 9:17 0.39
Tumor size 19.62 ± 8.88 19.33 ± 10.00 19.85 ± 8.05 0.85
Koos grade
I 5 (10.6%) 4 (19.0%) 1 (3.8%) 0.16
II 22 (46.8%) 9 (42.9%) 13 (50%) 0.78
III 17 (36.2%) 7 (33.3%) 10 (38.5%) 0.77
IV 3 (6.4%) 1 (4.8%) 2 (7.7%) 1
Hannover
classification
T1 7 (14.9%) 5 (23.8%) 2 (7.7%) 0.27
T2 8 (17.0%) 1 (4.8%) 7 (26.9%) 0.06
T3a 5 (10.6%) 2 (9.5%) 3 (11.5%) 1
T3b 10 (21.3%) 5 (23.8%) 5 (19.2%) 0.73
T4a 10 (21.3%) 5 (23.8%) 5 (19.2%) 0.73
T4b 7 (14.9%) 3 (14.3%) 4 (15.4%) 1
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Table 1. Cont.
Characteristics Tumor Origin
All Patients (n = 47) SVN (n = 21) IVN (n = 26) p-Value
Cystic component
Cystic 12 (25.5%) 3 (14.3%) 9 (34.6%) 0.18
Solid 35 (74.5%) 18 (85.7%) 17 (65.4%) 0.18
Surgical approach
TLA 34 (72.3%) 17 (81.0%) 17 (65.4%) 0.33
MFA 1 (2.1%) 1 (4.8%) 0 (0.0%) 0.11
RSA 8 (17.0%) 2 (9.5%) 6 (23.1%) 0.27
EETTA 4 (8.5%) 1 (4.8%) 3 (11.5%) 0.62
SVN, superior vestibular nerve; IVN, inferior vestibular nerve; M, male; F, female; TLA, translabyrinthine
approach; MFA, middle fossa approach, RSA; retrosigmoid approach; EETTA, exclusive endoscopic transcanal
transpromontorial approach.
2.3. Pure-Tone and Speech Audiometry
The pure-tone and speech audiograms were completed for all enrolled patients by
an experienced audiologist before surgery. The average pure-tone thresholds of 500, 1000,
2000, and 4000 Hz in the affected ear were defined as PTA4. The speech discrimination
score was defined as the percentage of correctly repeated 50 monosyllabic Korean words in
the sound intensity of the most comfortable hearing level. For both tests, the audiologist
used noise masking as needed in the patient’s unaffected ear.
2.4. Caloric Test
Binaural bithermal caloric irrigations (SLVNG, SLMED, Seoul, Korea) were performed
with the patient positioned in a chair reclined 30◦ to vertically orient the semicircular canals.
The external auditory canal was irrigated with 20 mL of cold water at 30 ◦C, followed
by 20 mL of hot water at 44 ◦C for 10 s after confirming the integrity of the tympanic
membrane. The induced nystagmus was recorded using electronystagmography in a dark
room with the patient’s eyes open, and a maximum slow-phase velocity of nystagmus was
measured following each irrigation. Canal weakness was defined as a > 25% asymmetry
based on Jongkees’ formula [20].
2.5. Cervical and Ocular Vestibular-Evoked Myogenic Potentials (cVEMP and oVEMP)
We measured cVEMPs and oVEMPs using the Audera system (Audera, GSI, Eden
Prairie, MN, USA) with short-tone bursts from earphones at a frequency of 500 Hz with
an amplitude of 100 dB. The cVEMPs were registered using surface electrodes placed on
the upper half of the ipsilateral sternocleidomastoid muscles, a reference electrode on
the mastoid, and a ground electrode on the forehead. The first positive–negative peak
(p13–n23) of the averaged electromyogram results was analyzed and recorded as the
cVEMP amplitude. For oVEMP, the electrode was placed directly beneath the patient’s
eye contralateral to the forehead ground electrode, and acoustic stimuli were applied to
the contralateral ear. The n10–p15 amplitudes of the averaged electromyogram results
were evaluated and recorded as the oVEMP amplitudes. Asymmetry ratios less than −0.36
or no response were considered abnormal responses, calculated as follows: (ipsilateral
amplitude—contralateral amplitude)/(ipsilateral amplitude + contralateral amplitude) at
100 dB nHL [21].
2.6. Video Head Impulse Test (vHIT)
The function of the six semicircular canals was evaluated using a three-dimensional
video head impulse test (vHIT, ICS Impulse, Otometrics, Taastrup, Denmark). Patients
were positioned at a distance of 1 m from a target located at eye level. To ensure reliability
of the examination process, goggles were fastened to the patient’s head with an elastic
band to minimize slippage. The examination was conducted by an experienced technician
blinded to the results of the clinical and MRI findings. The technician manually performed
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rotation more than 20 times (head rotation: 15–20◦, duration: 150–200 ms, peak velocity:
>150◦) on both sides of each plane. The VOR gain of the three semicircular canals was
calculated using the ratio of the area under the curve (AUC) for the eye velocity area
divided by the head velocity area, as automatically determined by the device. All vHIT
tests were conducted by a senior ENT technician blinded to the results regarding tumor
origin. The overt or covert saccades used in the analysis were defined as the occurrence of
more than 20% of trials with similar amplitude and latency during all vHIT trials.
2.7. Posturography
Posturography was performed on a computerized dynamic posturography platform
(EquiTest; Neurocom, Clackamas, OR, USA). A composite (COMP) score was calculated by
independently averaging the equilibrium score for conditions 1 and 2, adding them to the
equilibrium score from each trial of conditions 3–6, and finally dividing this sum by the
total number of trials. The ratio of C5 to C1 represented the vestibular contribution (VEST).
The detailed analysis methods were previously described [22].
2.8. Statistical Analysis
All statistical analyses were performed using the Statistical Package for the Social
Sciences for Windows version 20.0 (IBM Corp., Armonk, NY, USA). A p-value < 0.05 was
considered statistically significant. Quantitative parameters were described using means
± standard deviations (SDs). The independent t-test, Mann–Whitney U test, Pearson or
Spearman correlation analysis, and Fisher’s exact test were used to compare parameters
in this study. Each evaluation method was selected based on the normality of the sample.
Receiver operating characteristic (ROC) curve analysis was performed to identify which
parameters were useful in distinguishing SVN and IVN groups.
3. Results
3.1. Demographic Data of Patients and Surgical Results
Patient demographics and tumor characteristics are outlined in Table 1. Among
the 55 enrolled patients who underwent surgical removal of VS, the nerve of the tumor
origin in eight of them could not be clearly identified during the surgery; therefore, they
were not included in further analysis. Forty-seven patients were finally included, with
a mean age of 54.06 ± 13.50 years and a male to female ratio of 18:29. Tumor origin was
identified by a single experienced neuro-otologic surgeon (I.S. Moon). Tumors arose from
the SVN in 21 patients and the IVN in 26 patients. The mean extrameatal tumor size was
19.62 ± 8.88 mm, with 19.33 ± 10.00 mm for SVN origin and 19.85 ± 8.05 mm for IVN
origin. There were no significant differences between the SVN and IVN groups regarding
tumor characteristics, including tumor size, Koos grade, Hannover classification, cystic
component, or surgical approach (Table 1).
3.2. Cochleovestibular Function According to Tumor Origin
The PTA4 was 52 dB HL, with 40% speech discrimination in the SVN group and
60 dB HL with 45% speech discrimination in the IVN group. The mean caloric weaknesses
were 42% and 44% in the SVN and IVN groups, respectively. The mean VOR gain on the
ipsilesional side in the SVN group was 0.79 (SD = 0.22) in the AC, 0.83 (SD = 0.26) in the
HC, and 0.86 (SD = 0.22) in the PC. For the IVN group, the VOR gain was 0.85 (SD = 0.19)
in the AC, 0.80 (SD = 0.23) in the HC, and 0.65 (SD = 0.17) in the PC. We observed statistical
differences in VOR gain only in the ipsilesional PC (iPC) (p = 0.001) (Table 1 and Figure 1).
During cVEMPs testing, 16 patients (76.2%) in the SVN group and 21 (80.8%) in the IVN
group had abnormal responses. During oVMEPs testing, this was seen for 18 patients
(85.7%) in the SVN group and 23 (88.5%) in the IVN group. The abnormal response rates
for cVEMPs and oVEMPs did not differ significantly between the two groups (Table 2).
In addition, no statistical differences were observed in the composite scores or vestibular
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scores of posturography (Table 2). Vestibular function in relation to tumor origin is also
shown in Table 2.
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Table 2. Cochleovestibular function according to tumor origin.
Parameters Tumor Origin
SVN (n = 21) IVN (n = 26) p-Value
Pure-tone audiometry (PTA4) 51.90 ± 29.00 59.87 ± 25.38 0.32
Speech discrimination (%) 40.38 ± 35.42 44.67 ± 36.65 0.6
Ca al weakness (%) 41.83 ± 27.79 43.84 ± 23.98 0.8
vHIT
iAC
Gain 0.79 ± 0.22 0.85 ± 0.19 0.36
Overt saccades 3 2 0.64
Covert saccades 5 4 0.49
Any saccades 7 6 0.52
iHC
Gain 0.83 ± 0.26 0.80 ± 0.23 0.72
Overt saccades 16 17 0.53
Covert saccades 7 10 0.77
Any saccades 16 18 0.75
iPC
Gain 0.86 ± 0.22 0.65 ± 0.17 0.001
Overt saccades 8 17 0.08
Covert saccades 4 10 0.2
Any saccades 12 19 0.36
cAC
Gain 0.86 ± 0.13 0.87 ± 0.13 0.89
Overt saccades 3 0 0.08
Covert saccades 2 4 0.68
Any saccades 4 4 1
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Table 2. Cont.
Parameters Tumor Origin
SVN (n = 21) IVN (n = 26) p-Value
cHC
Gain 0.98 ± 0.13 0.99 ± 0.10 0.64
Overt saccades 8 6 0.34
Covert saccades 1 6 0.11
Any saccades 9 9 0.76
cPC
Gain 0.88 ± 0.14 0.83 ± 0.10 0.23
Overt saccades 6 7 1
Covert saccades 2 5 0.44
Any saccades 7 9 1
cVEMP (% abnormal responses) 16 (76.2%) 21 (80.8%) 1
oVEMP (% abnormal responses) 18 (85.7%) 23 (88.5%) 1
Posturography
Composite score 68.25 ± 9.43 60.77 ± 11.99 0.228
Vestibular score 56.00 ± 15.65 39.69 ± 22.69 0.468
SVN, superior vestibular nerve; IVN, inferior vestibular nerve; AC, anterior canal; HC, horizontal canal; PC,
posterior canal; i = ipsilesional; c = contralesional; cVEMP, cervical vestibular-evoked myogenic potentials;
oVEMP, ocular vestibular-evoked myogenic potentials.
3.3. vHIT to Identify the Nerve of Origin of VS
We plotted the ROC curve to determine whether VOR gain in the iPC had diagnostic
value in discriminating tumor origin. The AUC of the iPC was 0.801, indicating a good
parameter [23]. Tumors originating from the IVN could be diagnosed with a sensitivity
of 73% and a specificity of 80% when the iPC gain was below 0.74 (Figure 2). We also
observed that the asymmetry ratio of the PC calculated by Jonkees’ formula could not
provide additional diagnostic value in discriminating the two origins (AUC, 0.729).
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4. Discussion
This study was conducted to determine the differences in vestibular function testing
when VS originates from the IVN and SVN by quantitatively evaluating the results of a
relatively large number of VS patients for whom the origin was confirmed during surgery.
The advantage of a test battery that combines the caloric test, vHIT, and c or oVEMP lies in
the ability to identify patterns of nerve and end-organ involvement; vHIT can be used in
conjunction with air conduction c and oVEMP to identify four categories that characterize
patients with vestibular neuritis: SVN, IVN, both nerve divisions, and canal afferents
only [10]. Horizontal vHIT gain, the caloric test results, and oVEMP responses reflect
the superior afferent function, and posterior canal vHIT and cVEMP responses reflect the
inferior afferent function [10].
Based on these findings, we believe that the nerve origin of VS can be predicted using
vestibular function tests, including the caloric, vHIT, and VEMP tests. Since the origin of the
tumor is an important prognostic factor, several attempts have been made to predict it with
various vestibular function tests, hearing status, and by using MRI [6,12,13,15,16,24]. Due
to the close relationship between the tumor and cochlear nerve under the transverse crest
within the internal auditory canal, removal of VS originating from the IVN is considered
to be responsible for the low rate of hearing preservation, but it is also associated with an
increased chance of intraoperative trauma to the cochlear nerve [5,9]. This association is
supported by several studies demonstrating that 61% to 75% of patients whose tumors were
found intraoperatively to arise from the SVN had preserved hearing, while hearing was
preserved in only 16% to 28% of patients whose tumors were found to arise from the IVN
and for whom hearing preservation was attempted [5,6]. This information is useful in that
it further enables surgeons to determine the best surgical approach and accurately counsel
patients preoperatively based on their test results. However, most studies to preoperatively
predict the origin using functional vestibular tests have been unsuccessful; even when
they were successful, they were limited to relatively small tumors. As such, intraoperative
identification remains the only reliable method [15,16].
While deteriorated vestibular function could potentially be associated with a tumor
arising from the SVN or a large tumor arising from the IVN, a normal or localized abnor-
mal vestibular response is considered to indicate a small tumor. Therefore, the need to
adequately discern the origin of small tumors becomes somewhat reasonable according to
the vestibular functions [12,16,24]. However, when the tumor size exceeds medium and
most vestibular functions are deteriorated [15], the simple pathologic classification has
limitations in determining the nerve origin; in some cases, it is not even possible to make
a prediction. Therefore, we quantitatively evaluated vestibular functions, especially in
vHIT, at three semicircular canals in patients with schwannomas for whom the origin was
identified during surgery. Our findings demonstrated significant differences in gain in the
iPC, depending on the tumor origin (0.86 ± 0.22 in SVN and 0.65 ± 0.17 in IVN, p = 0.001).
In addition, the ROC curve showed that the difference of PC gain can distinguish the
origin of the tumor with a sensitivity of 73% and a specificity of 80% (Figure 2). However,
other vestibular function tests, including the caloric weakness, abnormal rate of the VEMP
test, and postural score, showed no differences between the two groups. Similar to our
results, Inoue et al. reported that the caloric test did not provide information regarding
nerve origin [24]. The specific value of VEMP in predicting outcomes varies among reports.
He et al. reported that SVN tumors showed an abnormal cVEMP response in about 50%
of cases, whereas, in IVN tumors, no or decreased cVEMP response was observed in all
cases [6]. Chen et al. also reported that, in patients with normal caloric responses and
no VEMP, the VS originated from the IVN [25]. The differences between our study and
others on VEMP indicate that, in VS cases larger than medium size, nerve origin cannot be
precisely predicted using conventional vestibular function tests. Other authors have also
shown that caloric tests and VEMP responses did not significantly differ between patients
with SVN and IVN schwannomas [11,13]. Tsutsumi et al. [12] reported that VEMP was not
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useful for preoperatively predicting the origin of schwannomas because of its tolerance for
minor dysfunction of the inferior vestibular afferent nerve.
Regarding vHIT, several attempts have been made to evaluate the vestibular function
related to nerve origin [15,16]. Taylor et al. [26] found little evidence of selective inferior or
superior nerve subtypes in 50 patients with VS, but a surgical correlation was not sought.
Recently, Rahne et al. [16] attempted to identify nerve origin by providing an independent
score for the presence or absence of vHIT and VEMP abnormalities with five VS patients;
they were able to correctly predict the origin in four cases. However, the tumors that could
be identified by the scoring system were small (Koos grade I, II). Thus, tumor size seems to
be a limiting factor for prediction using these scoring systems. Another study demonstrated
the usefulness of vHIT to correctly identify the nerve of origin in 89.7% of cases [15]. In
this study, the results of vHIT were evaluated using normative values and classified into
normal pattern, isolated SVN, isolated IVN, predominant SVN, and predominant IVN.
However, in our study, posterior vHIT gain was identified as the only reliable factor that
could distinguish the two origins. In most cases, an experienced surgeon can identify the
nerve of origin intraoperatively. Therefore, the risk of intraoperative misjudgment was
considered very low in our study.
Reliable preoperative identification of the nerve of origin in patients with VS would
be useful; it would provide information regarding the chance of hearing preservation
when surgery is recommended. Therefore, in a situation where an inferior VS is suspected
from vHIT analysis, the retrosigmoid approach, which allows direct visualization of both
vestibular nerves on the IAC, may have an advantage for tumor removal, and better hearing
preservation can be expected.
Our results indicate that VOR gain in the iPC has a localizing value to predict the
nerve origin in patients with VS. Other cochleovestibular function tests have limited value
to discriminate nerve origins, especially for cases of large VS.
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